MARÍA JOSÉ
SÁNCHEZ PÉREZ
DOCENTE INVITADA
Javier
Rejas Gutiérrez
Publicaciones en las que colabora con Javier Rejas Gutiérrez (8)
2019
-
Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 19, Núm. 1, pp. 45-57
2018
-
Clinical and economic consequences of treating patients with peripheral neuropathic pain with brand name or generic drugs in routine clinical practice: The effects of age and sex
Neurologia, Vol. 33, Núm. 3, pp. 141-153
-
Cost of treating peripheral neuropathic pain with pregabalin or gabapentin at therapeutic doses in routine practice
Journal of Comparative Effectiveness Research, Vol. 7, Núm. 7, pp. 615-625
2017
-
Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity
Journal of Evaluation in Clinical Practice, Vol. 23, Núm. 2, pp. 402-412
2015
-
Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
Drug Design, Development and Therapy, Vol. 9, pp. 4329-4340
2013
-
Clinical and resource utilization patterns in patients with refractory neuropathic pain prescribed pregabalin for the first time in routine medical practice in primary care settings in Spain
Pain Medicine (United States), Vol. 14, Núm. 12, pp. 1954-1963
2011
-
Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use
European Addiction Research, Vol. 17, Núm. 5, pp. 262-270
2005
-
Prevalencia del dolor neuropático en España: Implicaciones clínicas, laborales y asistenciales
Medicina Clinica, Vol. 125, Núm. 6, pp. 221-229